Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

The DDR1 receptor tyrosine kinase is activated by matrix collagens and has been implicated in numerous cellular functions such as proliferation, differentiation, adhesion, migration, and invasion. Here we report the discovery of a potent and selective DDR1 inhibitor, DDR1-IN-1, and present the 2.2 Å...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Kim, H, Tan, L, Weisberg, E, Liu, F, Canning, P, Choi, H, Ezell, SA, Wu, H, Zhao, Z, Wang, J, Mandinova, A, Griffin, J, Bullock, A, Liu, Q, Lee, S, Gray, N
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2013

Ижил төстэй зүйлс

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.
-н: Kim, H, зэрэг
Хэвлэсэн: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors
-н: Canning, P, зэрэг
Хэвлэсэн: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
-н: Canning, P, зэрэг
Хэвлэсэн: (2014)

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
-н: Maria G. Nava, зэрэг
Хэвлэсэн: (2023-02-01)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
-н: López-Ramos, M, зэрэг
Хэвлэсэн: (2010)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
-н: López-Ramos, M, зэрэг
Хэвлэсэн: (2010)

Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
-н: William A. Denny, зэрэг
Хэвлэсэн: (2021-11-01)

Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
-н: Panupong Mahalapbutr, зэрэг
Хэвлэсэн: (2024-02-01)

Discovery of Novel Naphthoquinone–Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling
-н: Ronnakorn Leechaisit, зэрэг
Хэвлэсэн: (2023-08-01)

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
-н: Patrice Dubreuil, зэрэг
Хэвлэсэн: (2009-09-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
-н: Xu H, зэрэг
Хэвлэсэн: (2019-07-01)

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
-н: Sudarshan R Iyer, зэрэг
Хэвлэсэн: (2023-10-01)

Recent Advances in Discovery of New Tyrosine Kinase Inhibitors Using Computational Methods
-н: Vesna Rastija
Хэвлэсэн: (2019-08-01)

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
-н: Chunmin Yang, зэрэг
Хэвлэсэн: (2022-05-01)

Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.
-н: Hellwig, S, зэрэг
Хэвлэсэн: (2012)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights (September, pg 3175, 2010)
-н: Lopez-Ramos, M, зэрэг
Хэвлэсэн: (2011)

Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1
-н: C. Reger de Moura, зэрэг
Хэвлэсэн: (2024-01-01)

Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells.
-н: Ellen Weisberg, зэрэг
Хэвлэсэн: (2013-01-01)

First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2
-н: Ian M. Catlett, зэрэг
Хэвлэсэн: (2023-01-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
-н: Maria Dimou, зэрэг
Хэвлэсэн: (2014-01-01)

TYROSINE KINASE INHIBITORS AND PREGNANCY
-н: Elisabetta Abruzzese, зэрэг
Хэвлэсэн: (2014-04-01)

Second-generation inhibitors of Bruton tyrosine kinase
-н: Jingjing Wu, зэрэг
Хэвлэсэн: (2016-09-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
-н: Cornelius Hempel, зэрэг
Хэвлэсэн: (2017-01-01)

Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents
-н: Yangyang Yao, зэрэг
Хэвлэсэн: (2017-10-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
-н: John J. Ryan, MD
Хэвлэсэн: (2016-12-01)

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?
-н: Zhao, Z, зэрэг
Хэвлэсэн: (2014)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
-н: Ainun Nizar Masbuchin, зэрэг
Хэвлэсэн: (2022-09-01)

Tyrosine kinase inhibitor Tofacitinib. Safety issues
-н: G. V. Lukina, зэрэг
Хэвлэсэн: (2015-12-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
-н: Huang JT, зэрэг
Хэвлэсэн: (2022-11-01)

Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
-н: Mark C Weir, зэрэг
Хэвлэсэн: (2017-01-01)

miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors
-н: Tatsuki Shibuta, зэрэг
Хэвлэсэн: (2022-06-01)

Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity
-н: Chris Liang, зэрэг
Хэвлэсэн: (2022-03-01)

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
-н: Jiangnan Liu, зэрэг
Хэвлэсэн: (2024-03-01)

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors
-н: Wu J, зэрэг
Хэвлэсэн: (2020-09-01)

Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders
-н: Muhammad Waleed Iqbal, зэрэг
Хэвлэсэн: (2025-01-01)

Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
-н: Pitsiou G, зэрэг
Хэвлэсэн: (2014-10-01)

509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer
-н: Matthew Walters, зэрэг
Хэвлэсэн: (2020-11-01)

Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma
-н: Wei Dai, зэрэг
Хэвлэсэн: (2021-05-01)

Tetrahydroisoquinoline-7-carboxamide derivatives as new selective discoidin domain receptor 1 (DDR1) inhibitors
-н: Bullock, A, зэрэг
Хэвлэсэн: (2017)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
-н: Evan Pisick, зэрэг
Хэвлэсэн: (2004-01-01)